Literature DB >> 35943572

Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?

Emmanuel Novy1,2, Thomas François1, Amandine Luc3, Elise Pape4,5, Julien Scala-Bertola6,7.   

Abstract

Entities:  

Year:  2022        PMID： 35943572     DOI： 10.1007/s00134-022-06830-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  4 in total

Review 1.  Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR).

Authors:  Romain Guilhaumou; Sihem Benaboud; Youssef Bennis; Claire Dahyot-Fizelier; Eric Dailly; Peggy Gandia; Sylvain Goutelle; Sandrine Lefeuvre; Nicolas Mongardon; Claire Roger; Julien Scala-Bertola; Florian Lemaitre; Marc Garnier
Journal:  Crit Care       Date:  2019-03-29       Impact factor: 9.097

2.  Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study.

Authors:  A Ceccato; A Russo; E Barbeta; P Oscanoa; G Tiseo; A Gabarrus; P Di Giannatale; S Nogas; C Cilloniz; F Menichetti; M Ferrer; M Niederman; M Falcone; A Torres
Journal:  Crit Care       Date:  2021-12-16       Impact factor: 9.097

Review 3.  TDM is dead. Long live TCI!

Authors:  Nick Holford; Guangda Ma; David Metz
Journal:  Br J Clin Pharmacol       Date:  2020-07-01       Impact factor: 3.716

4.  Another trial for the TARGET trial. Author's reply.

Authors:  Stefan Hagel; Mathias W Pletz; Thomas Lehmann
Journal:  Intensive Care Med       Date:  2022-03-23       Impact factor: 41.787
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.